help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-2383
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/7/2761    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, H.-T.
Right arrow Articles by Guo, I.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, H.-T.
Right arrow Articles by Guo, I.-C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 7 2761-2769
Copyright © 2006 by The Endocrine Society

Leptin Interferes with Adrenocorticotropin/3',5'-Cyclic Adenosine Monophosphate (cAMP) Signaling, Possibly through a Janus Kinase 2-Phosphatidylinositol 3-Kinase/Akt-Phosphodiesterase 3-cAMP Pathway, to Down-Regulate Cholesterol Side-Chain Cleavage Cytochrome P450 Enzyme in Human Adrenocortical NCI-H295 Cell Line

Hao-Ting Hsu1, Yuan-Ching Chang1, Yi-Ning Chiu, Chien-Liang Liu, King-Jen Chang and Ing-Cherng Guo

Department of Veterinary Medicine (H.-T.H., Y.-C.C., Y.-N.C., I.-C.G.), College of Bio-Resources and Agriculture, and Department of Surgery (K.-J.C.), National Taiwan University Hospital, National Taiwan University, Taipei 10617, Taiwan; Department of Surgery (Y.-C.C., C.-L.L.), Mackay Memorial Hospital, Taipei 10449, Taiwan; and Mackay Medicine, Nursing and Management College (Y.-C.C., C.-L.L.), Taipei 11260, Taiwan

Address all correspondence and requests for reprints to: Ing-Cherng Guo, Department of Veterinary Medicine, College of Bio-Resources and Agriculture, National Taiwan University, Taipei 10617, Taiwan. E-mail: iguo{at}ntu.edu.tw.

Context: Obesity has adverse effects on adrenocortical functions. Adipocyte-derived leptin, a biomarker molecule of obesity, may directly control adrenal steroidogenesis via an unclear mechanism.

Objective: We studied the mechanism underlying leptin action on adrenal steroidogenesis in human adrenocortical NCI-H295 tumor cell line.

Methods: Levels of progesterone, cortisol, and cAMP were determined by ELISA. Western blotting was used to detect protein amounts of P450 side-chain cleavage (P450scc), Janus kinase 2 (JAK2), Akt, and their phosphorylated forms. The mRNA expressions of P450scc and leptin receptors were measured by RT-PCR and real-time PCR. P450scc promoter activity was analyzed with a luciferase reporter system.

Results: Cholera toxin mimicked ACTH action by increasing adrenal cAMP levels and steroid secretion. Leptin did not affect basal release but significantly inhibited ACTH/cholera toxin-induced steroid secretion. The concomitant inhibitions by leptin on cholera toxin-induced protein and ACTH/cholera toxin-induced mRNA expression of P450scc were confirmed. Leptin inhibited ACTH/cholera toxin-induced CYP11A1 promoter activity via a known cAMP-responsive region located between –1.7 and –1.5 kb. Leptin activated phosphorylations of JAK2 and Akt. Inhibitory effects of leptin on ACTH/cholera toxin-induced cAMP levels, CYP11A1 promoter activity, and steroid secretion were blunted by either inhibitor of JAK2 (AG490) or phosphatidylinositol 3-kinase/Akt (wortmannin) as well as inhibitors of cAMP-degrading phosphodiesterases (PDEs), including nonspecific 3-isobutyl-1-methylxanthine and PDE3-specific SKF94836. Leptin failed to affect the inductions of CYP11A1 promoter activity and steroid secretion by PDE-nonhydrolyzable N6-monobutyryl-cAMP.

Conclusions: Leptin interferes with ACTH/cAMP signaling, possibly through a cAMP-degrading mechanism involving activation of JAK2, phosphatidylinositol 3-kinase, and PDE3, to down-regulate P450scc expression and consequent adrenal steroidogenesis.




This article has been cited by other articles:


Home page
J. Nutr.Home page
T. Remer, T. Dimitriou, and C. Maser-Gluth
Renal Net Acid Excretion and Plasma Leptin Are Associated with Potentially Bioactive Free Glucocorticoids in Healthy Lean Women
J. Nutr., February 1, 2008; 138(2): 426S - 430S.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C. Chen, Y.-C. Chang, C.-L. Liu, T.-P. Liu, K.-J. Chang, and I.-C. Guo
Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway
Endocr. Relat. Cancer, June 1, 2007; 14(2): 513 - 529.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I.-C. Guo, C.-Y. Huang, C.-K. L. Wang, and B.-c. Chung
Activating Protein-1 Cooperates with Steroidogenic Factor-1 to Regulate 3',5'-Cyclic Adenosine 5'-Monophosphate-Dependent Human CYP11A1 Transcription in Vitro and in Vivo
Endocrinology, April 1, 2007; 148(4): 1804 - 1812.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society